Clinical Trials Browser

Phase 1/2 × Malignant Ascites × molgramostim × Clear all

NCT05501340 2022-08-15

PD-1 Inhibitor Intraperitoneal Perfusion Combined With PRaG Therapy for Malignant Ascites

Phase 1/2 Unknown

Malignant Ascites